Insider · CIK 0001534986
Joao Siffert MD
Files at DSGN (Design Therapeutics, Inc.). First filing Dec 21, 2022, latest Dec 21, 2022.
In brief
Joao Siffert MD files SEC Form 4 as CEO, president and director at DSGN (Design Therapeutics, Inc.). Since Dec 21, 2022, Joao Siffert MD has reported 1 open-market buy worth $63k and 0 open-market sells worth $0, the latest filed on Dec 21, 2022.
A track record needs three past buys with six months of prices behind them; Joao Siffert MD has 0, so none is measured yet.
The newest scored trade: bought $63k of DSGN on Dec 19, 2022, filed Dec 21, 2022, scored 69 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DSGN: Design Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 69Notable | Design Therapeutics, Inc. | $63k 7,450 shares | +6% | +6% from low-67% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | DSGN Design Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +415,000 | $0.00 | $0 | 415,000 | Feb 3, 2023 |
| Dec 19, 2022 | DSGN Design Therapeutics, Inc. | POpen-market purchase Common Stock | +1,150 | $8.47 | $9,741 | 126,319 | Dec 21, 2022 |
| Dec 20, 2022 | DSGN Design Therapeutics, Inc. | POpen-market purchase Common Stock | +6,300 | $8.38 | $53k | 132,619 | Dec 21, 2022 |
Questions about Joao Siffert MD
Answered from the filings on this page, as of the latest one.
Is Joao Siffert MD buying or selling?
Not in the last 12 months. Joao Siffert MD's latest open-market trade on SEC Form 4 was bought $63k of DSGN on Dec 19, 2022.
How did Joao Siffert MD's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Joao Siffert MD has 0.
Where does Joao Siffert MD file Form 4?
Joao Siffert MD has filed Form 4 at DSGN (Design Therapeutics, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.